Document is current
Any future updates will be listed below
-
Authors
Ma, Weijie
Xue, Ruobing
Zhu, Zheng
Farrukh, Hizra
Song, Wenru
Li, Tianhong
Zheng, Lei
Pan, Chong-xian
- License Information
-
More Information
Article History
Received: 8 September 2022
Accepted: 4 January 2023
First Online: 16 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: LZ: grant support from Bristol-Meyer Squibb, Merck, AstraZeneca, iTeos, Amgen, NovaRock, Inxmed, and Halozyme; paid consultant/Advisory Board Member at Biosion, Alphamab, NovaRock, Ambrx, Akrevia/Xilio, Datarevive, QED, Xilio, Natera, Novagenesis, Snow Lake Captials, and Mingruizhiyao; and shareholder at Alphamab and Mingruzhiyao. WS: an employee of Kira Pharmaceuticals. CXP is a co-founder and shareholder of LP Therapeutics.
